Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 124

1.

Olanzapine versus haloperidol: acute phase results of the international double-blind olanzapine trial.

Beasley CM Jr, Hamilton SH, Crawford AM, Dellva MA, Tollefson GD, Tran PV, Blin O, Beuzen JN.

Eur Neuropsychopharmacol. 1997 May;7(2):125-37.

PMID:
9169300
[PubMed - indexed for MEDLINE]
2.

Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol.

Lieberman JA, Tollefson G, Tohen M, Green AI, Gur RE, Kahn R, McEvoy J, Perkins D, Sharma T, Zipursky R, Wei H, Hamer RM; HGDH Study Group.

Am J Psychiatry. 2003 Aug;160(8):1396-404.

PMID:
12900300
[PubMed - indexed for MEDLINE]
3.

Extrapyramidal symptoms and tolerability of olanzapine versus haloperidol in the acute treatment of schizophrenia.

Tran PV, Dellva MA, Tollefson GD, Beasley CM Jr, Potvin JH, Kiesler GM.

J Clin Psychiatry. 1997 May;58(5):205-11. Erratum in: J Clin Psychiatry 1997 Jun;58(6):275.

PMID:
9184614
[PubMed - indexed for MEDLINE]
4.

Comparative efficacy of olanzapine and haloperidol for patients with treatment-resistant schizophrenia.

Breier A, Hamilton SH.

Biol Psychiatry. 1999 Feb 15;45(4):403-11.

PMID:
10071708
[PubMed - indexed for MEDLINE]
5.

Olanzapine versus haloperidol treatment in first-episode psychosis.

Sanger TM, Lieberman JA, Tohen M, Grundy S, Beasley C Jr, Tollefson GD.

Am J Psychiatry. 1999 Jan;156(1):79-87.

PMID:
9892301
[PubMed - indexed for MEDLINE]
6.

Olanzapine versus haloperidol in the treatment of schizophrenia and other psychotic disorders: quality of life and clinical outcomes of a randomized clinical trial.

Revicki DA, Genduso LA, Hamilton SH, Ganoczy D, Beasley CM Jr.

Qual Life Res. 1999 Aug;8(5):417-26.

PMID:
10474283
[PubMed - indexed for MEDLINE]
7.

Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia.

Kinon BJ, Basson BR, Gilmore JA, Tollefson GD.

J Clin Psychiatry. 2001 Feb;62(2):92-100.

PMID:
11247108
[PubMed - indexed for MEDLINE]
8.

Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch study.

Lindenmayer JP, Czobor P, Volavka J, Lieberman JA, Citrome L, Sheitman B, Chakos M, McEvoy JP.

J Clin Psychiatry. 2002 Oct;63(10):931-5.

PMID:
12416603
[PubMed - indexed for MEDLINE]
9.

Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial.

Tollefson GD, Beasley CM Jr, Tran PV, Street JS, Krueger JA, Tamura RN, Graffeo KA, Thieme ME.

Am J Psychiatry. 1997 Apr;154(4):457-65.

PMID:
9090331
[PubMed - indexed for MEDLINE]
10.

An integrated analysis of acute treatment-emergent extrapyramidal syndrome in patients with schizophrenia during olanzapine clinical trials: comparisons with placebo, haloperidol, risperidone, or clozapine.

Carlson CD, Cavazzoni PA, Berg PH, Wei H, Beasley CM, Kane JM.

J Clin Psychiatry. 2003 Aug;64(8):898-906.

PMID:
12927004
[PubMed - indexed for MEDLINE]
11.

Olanzapine vs haloperidol in geriatric schizophrenia: analysis of data from a double-blind controlled trial.

Kennedy JS, Jeste D, Kaiser CJ, Golshan S, Maguire GA, Tollefson G, Sanger T, Bymaster FP, Kinon BJ, Dossenbach M, Gilmore JA, Breier A.

Int J Geriatr Psychiatry. 2003 Nov;18(11):1013-20.

PMID:
14618553
[PubMed - indexed for MEDLINE]
12.

Effective resolution with olanzapine of acute presentation of behavioral agitation and positive psychotic symptoms in schizophrenia.

Kinon BJ, Roychowdhury SM, Milton DR, Hill AL.

J Clin Psychiatry. 2001;62 Suppl 2:17-21.

PMID:
11232746
[PubMed - indexed for MEDLINE]
13.

Depressive signs and symptoms in schizophrenia: a prospective blinded trial of olanzapine and haloperidol.

Tollefson GD, Sanger TM, Lu Y, Thieme ME.

Arch Gen Psychiatry. 1998 Mar;55(3):250-8. Erratum in: Arch Gen Psychiatry 1998 Nov;55(11):1052.

PMID:
9510219
[PubMed - indexed for MEDLINE]
14.

Olanzapine as alternative therapy for patients with haloperidol-induced extrapyramidal symptoms: results of a multicenter, collaborative trial in Latin America.

Costa e Silva JA, Alvarez N, Mazzotti G, Gattaz WF, Ospina J, Larach V, Starkstein S, Oliva D, Cousins L, Tohen M, Taylor CC, Wang J, Tran PV.

J Clin Psychopharmacol. 2001 Aug;21(4):375-81.

PMID:
11476121
[PubMed - indexed for MEDLINE]
15.

[Safety and efficacy of olanzapine versus perphenazine in patients with schizophrenia: results of multicenter, 18-week, double-blind clinical trial].

Jarema M, Olajossy M, Chrzanowski W, Araszkiewicz A, Landowski J, Rybakowski J, Bilikiewicz A, Bomba J, Debowska G.

Psychiatr Pol. 2003 Jul-Aug;37(4):641-55. Polish.

PMID:
14560493
[PubMed - indexed for MEDLINE]
16.

Switching to olanzapine from previous antipsychotics: a regional collaborative multicenter trial assessing 2 switching techniques in Asia Pacific.

Lee CT, Conde BJ, Mazlan M, Visanuyothin T, Wang A, Wong MM, Walker DJ, Roychowdhury SM, Wang H, Tran PV.

J Clin Psychiatry. 2002 Jul;63(7):569-76.

PMID:
12143912
[PubMed - indexed for MEDLINE]
17.

Intramuscular olanzapine and intramuscular haloperidol in acute schizophrenia: antipsychotic efficacy and extrapyramidal safety during the first 24 hours of treatment.

Wright P, Lindborg SR, Birkett M, Meehan K, Jones B, Alaka K, Ferchland-Howe I, Pickard A, Taylor CC, Roth J, Battaglia J, Bitter I, Chouinard G, Morris PL, Breier A.

Can J Psychiatry. 2003 Dec;48(11):716-21.

PMID:
14733451
[PubMed - indexed for MEDLINE]
18.

Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial.

Beasley CM Jr, Tollefson G, Tran P, Satterlee W, Sanger T, Hamilton S.

Neuropsychopharmacology. 1996 Feb;14(2):111-23.

PMID:
8822534
[PubMed - indexed for MEDLINE]
Free Article
19.

Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone.

Basson BR, Kinon BJ, Taylor CC, Szymanski KA, Gilmore JA, Tollefson GD.

J Clin Psychiatry. 2001 Apr;62(4):231-8.

PMID:
11379836
[PubMed - indexed for MEDLINE]
20.

Clinical and economic outcomes of olanzapine compared with haloperidol for schizophrenia. Results from a randomised clinical trial.

Hamilton SH, Revicki DA, Edgell ET, Genduso LA, Tollefson G.

Pharmacoeconomics. 1999 May;15(5):469-80.

PMID:
10537964
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk